Recently, the U.S. House Labor Health and Human Services Appropriations Subcommittee approved a $300 million increase for Alzheimer’s research at the National Institutes of Health (NIH).
In response, the Senate Labor Health and Human Services Appropriations Subcommittee demonstrated its bipartisan commitment to Alzheimer’s funding by approving an approximately $350 million increase for Alzheimer’s research at the NIH, increasing existing funding by 60 percent.
This increase in funding was requested by advocates from GHR partner Alzheimer’s Association, who have worked to promote this funding through many initiatives, including the Alzheimer’s Association Advocacy Forum in March, when more than 1,000 advocates went to Capitol Hill to request an increase in Alzheimer’s research funding.
This exciting news is part of a year-long process, and precedes a formal consideration of the legislation. The full House and Senate Appropriations Committees will consider the proposal, and the funding increase will occur when a bill is passed by Congress and signed into law, likely towards end of the year.
These large-scale funding efforts and public-private collaborations are essential to the effort to treat and prevent Alzheimer’s disease. To learn more about how GHR is targeting funding to improve some of the largest research efforts in the field, contact us.